On April 30, 2026, the FDA proposed formally excluding semaglutide, tirzepatide, and liraglutide from the 503B Bulks List - which would eliminate the remaining legal pathway for 503B outsourcing facilities to compound these medications in bulk
Therapies with faster or no titration could improve patient and provider experience
Tirzepatide tapering schedule Tirzepatide tapering follows the same principles but uses different dose steps
Because the peptide engages GIPR, GLP-1R, and GCGR within a single molecular scaffold, it is especially useful in experimental models designed to examine how receptor signaling, energy metabolism, and endocrine pathway regulation interact across tissues rather than in isolation
Key highlights Retatrutide is an emerging blockbuster weight loss medication that acts on three receptors (GLP-1, GIP, and glucagon) simultaneously to suppress appetite and promote weight reduction
But if your breakfast has at least two, you're already ahead of skipping the meal entirely
